|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gonzalez-Angulo AM, Morales-Vasquez F and
Hortobagyi GN: Overview of resistance to systemic therapy in
patients with breast cancer. Adv Exp Med Biol. 608:1–22. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vu T and Claret FX: Trastuzumab: Updated
mechanisms of action and resistance in breast cancer. Front Oncol.
2:622012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Robidoux A, Tang G, Rastogi P, Geyer CE
Jr, Azar CA, Atkins JN, Fehrenbacher L, Bear HD, Baez-Diaz L,
Sarwar S, et al: Lapatinib as a component of neoadjuvant therapy
for HER2-positive operable breast cancer (NSABP protocol B-41): An
open-label, randomised phase 3 trial. Lancet Oncol. 14:1183–1192.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Narayan M, Wilken JA, Harris LN, Baron AT,
Kimbler KD and Maihle NJ: Trastuzumab-induced HER reprogramming in
'resistant' breast carcinoma cells. Cancer Res. 69:2191–2194. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wolff AC, Hammond ME, Schwartz JN, Hagerty
KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer
A, et al American Society of Clinical Oncology/College of American
Pathologists: American Society of Clinical Oncology/College of
American Pathologists guideline recommendations for human epidermal
growth factor receptor 2 testing in breast cancer. Arch Pathol Lab
Med. 131:18–43. 2007.PubMed/NCBI
|
|
7
|
Donepudi MS, Kondapalli K, Amos SJ and
Venkanteshan P: Breast cancer statistics and markers. J Cancer Res
Ther. 10:506–511. 2014.PubMed/NCBI
|
|
8
|
ENCODE Project Consortium: An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang S, Qin C, Cao G, Xin W, Feng C and
Zhang W: Systematic analysis of long non-coding RNAs in the
senescence-accelerated mouse prone 8 brain using RNA sequencing.
Mol Ther Nucleic Acids. 5:e3432016. View Article : Google Scholar
|
|
11
|
Brockdorff N: Non-coding RNA and Polycomb
recruitment. RNA. 19:429–442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li P, Zhang X, Wang H, Wang L, Liu T, Du
L, Yang Y and Wang C: MALAT1 is associated with poor response to
oxaliplatin-based chemotherapy in colorectal cancer patients and
promotes chemo-resistance through EZH2. Mol Cancer Ther.
16:739–751. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Arai S, Song X, Reichart D, Du K,
Pascual G, Tempst P, Rosenfeld MG, Glass CK and Kurokawa R: Induced
ncRNAs allosterically modify RNA-binding proteins in cis to inhibit
transcription. Nature. 454:126–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee TH, D'Asti E, Magnus N, Al-Nedawi K,
Meehan B and Rak J: Microvesicles as mediators of intercellular
communication in cancer - the emerging science of cellular
'debris'. Semin Immunopathol. 33:455–467. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Théry C, Ostrowski M and Segura E:
Membrane vesicles as conveyors of immune responses. Nat Rev
Immunol. 9:581–593. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pefanis E, Wang J, Rothschild G, Lim J,
Kazadi D, Sun J, Federation A, Chao J, Elliott O, Liu ZP, et al:
RNA exosome-regulated long non-coding RNA transcription controls
super-enhancer activity. Cell. 161:774–789. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kourembanas S: Exosomes: Vehicles of
intercellular signaling, biomarkers, and vectors of cell therapy.
Annu Rev Physiol. 77:13–27. 2015. View Article : Google Scholar
|
|
18
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar
|
|
19
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi SJ, Wang LJ, Yu B, Li YH, Jin Y and
Bai XZ: LncRNA-ATB promotes trastuzumab resistance and
invasion-metastasis cascade in breast cancer. Oncotarget.
6:11652–11663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Soo CY, Song Y, Zheng Y, Campbell EC,
Riches AC, Gunn-Moore F and Powis SJ: Nanoparticle tracking
analysis monitors microvesicle and exosome secretion from immune
cells. Immunology. 136:192–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu SY, Huang X and Cheong KL: Recent
advances in marine algae polysaccharides: Isolation, structure, and
activities. Mar Drugs. 15:152017. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Baker SC, Bauer SR, Beyer RP, Brenton JD,
Bromley B, Burrill J, Causton H, Conley MP, Elespuru R, Fero M, et
al: The External RNA Controls Consortium: A progress report. Nat
Methods. 2:731–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schindelin J, Rueden CT, Hiner MC and
Eliceiri KW: The ImageJ ecosystem: An open platform for biomedical
image analysis. Mol Reprod Dev. 82:518–529. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kogure T, Lin WL, Yan IK, Braconi C and
Patel T: Intercellular nanovesicle-mediated microRNA transfer: A
mechanism of environmental modulation of hepatocellular cancer cell
growth. Hepatology. 54:1237–1248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xin H, Li Y, Buller B, Katakowski M, Zhang
Y, Wang X, Shang X, Zhang ZG and Chopp M: Exosome-mediated transfer
of miR-133b from multipotent mesenchymal stromal cells to neural
cells contributes to neurite outgrowth. Stem Cells. 30:1556–1564.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Z, Wang N, Li W, Liu P, Chen Q, Situ
H, Zhong S, Guo L, Lin Y, Shen J, et al: Caveolin-1 mediates
chemoresistance in breast cancer stem cells via β-catenin/ABCG2
signaling pathway. Carcinogenesis. 35:2346–2356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu D and Hung MC: Overexpression of ErbB2
in cancer and ErbB2-targeting strategies. Oncogene. 19:6115–6121.
2000. View Article : Google Scholar
|
|
30
|
Berry DA, Cronin KA, Plevritis SK, Fryback
DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD and
Feuer EJ; Cancer Intervention and Surveillance Modeling Network
(CISNET) Collaborators: Effect of screening and adjuvant therapy on
mortality from breast cancer. N Engl J Med. 353:1784–1792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pegram MD, Finn RS, Arzoo K, Beryt M,
Pietras RJ and Slamon DJ: The effect of HER-2/neu overexpression on
chemotherapeutic drug sensitivity in human breast and ovarian
cancer cells. Oncogene. 15:537–547. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Parise C and Caggiano V: Disparities in
the risk of the ER/PR/HER2 breast cancer subtypes among Asian
Americans in California. Cancer Epidemiol. 38:556–562. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Telli ML, Chang ET, Kurian AW, Keegan TH,
McClure LA, Lichtensztajn D, Ford JM and Gomez SL: Asian ethnicity
and breast cancer subtypes: A study from the California Cancer
Registry. Breast Cancer Res Treat. 127:471–478. 2011. View Article : Google Scholar
|
|
34
|
Kurian AW, Fish K, Shema SJ and Clarke CA:
Lifetime risks of specific breast cancer subtypes among women in
four racial/ethnic groups. Breast Cancer Res. 12:R992010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Denzer K, Kleijmeer MJ, Heijnen HF,
Stoorvogel W and Geuze HJ: Exosome: From internal vesicle of the
multivesicular body to intercellular signaling device. J Cell Sci.
113:3365–3374. 2000.PubMed/NCBI
|
|
37
|
van den Boorn JG, Dassler J, Coch C,
Schlee M and Hartmann G: Exosomes as nucleic acid nanocarriers. Adv
Drug Deliv Rev. 65:331–335. 2013. View Article : Google Scholar
|
|
38
|
Kucharzewska P and Belting M: Emerging
roles of extracellular vesicles in the adaptive response of tumour
cells to microenvironmental stress. J Extracell Vesicles. 2:22013.
View Article : Google Scholar
|
|
39
|
Mercer TR and Mattick JS: Structure and
function of long non-coding RNAs in epigenetic regulation. Nat
Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang H, Fu H, Xu W and Zhang X: Exosomal
non-coding RNAs: A promising cancer biomarker. Clin Chem Lab Med.
54:1871–1879. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Q, Shao Y, Zhang X, Zheng T, Miao M,
Qin L, Wang B, Ye G, Xiao B and Guo J: Plasma long non-coding RNA
protected by exosomes as a potential stable biomarker for gastric
cancer. Tumour Biol. 36:2007–2012. 2015. View Article : Google Scholar
|
|
42
|
Sadikovic B, Fernandes P, Zhang VW, Ward
PA, Miloslavskaya I, Rhead W, Rosenbaum R, Gin R, Roa B and Fang P:
Mutation Update for UBE3A variants in Angelman syndrome. Hum Mutat.
35:1407–1417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu G, Ye Z, Zhao X and Ji Z: SP1-induced
up-regulation of lncRNA SNHG14 as a ceRNA promotes migration and
invasion of clear cell renal cell carcinoma by regulating N-WASP.
Am J Cancer Res. 7:2515–2525. 2017.
|
|
44
|
Zhang J, Fan D, Jian Z, Chen GG and Lai
PB: Cancer specific long non-coding RNAs show differential
expression patterns and competing endogenous RNA potential in
hepatocellular carcinoma. PLoS One. 10:e01410422015. View Article : Google Scholar
|
|
45
|
Yue Y, Zhang J, Yang L, Liu S, Qi J, Cao
Q, Zhou C, Wang Y, Kijlstra A, Yang P, et al: Association of long
non-coding RNAs polymorphisms with ankylosing spondylitis,
Vogt-Koyanagi-Harada disease, and Behcet's disease. Invest
Ophthalmol Vis Sci. 59:1158–1166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tan Q, Yu Y, Li N, Jing W, Zhou H, Qiu S,
Liang C, Yu M and Tu J: Identification of long non-coding RNA 00312
and 00673 in human NSCLC tissues. Mol Med Rep. 16:4721–4729. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tan Q, Zuo J, Qiu S, Yu Y, Zhou H, Li N,
Wang H, Liang C, Yu M and Tu J: Identification of circulating long
non-coding RNA GAS5 as a potential biomarker for non-small cell
lung cancer diagnosisnon-small cell lung cancer, long non-coding
RNA, plasma, GAS5, biomarker. Int J Oncol. 50:1729–1738. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim KM, Abdelmohsen K, Mustapic M,
Kapogiannis D and Gorospe M: RNA in extracellular vesicles. Wiley
Interdiscip Rev RNA. 8:82017. View Article : Google Scholar
|
|
49
|
Boukouris S and Mathivanan S: Exosomes in
bodily fluids are a highly stable resource of disease biomarkers.
Proteomics Clin Appl. 9:358–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Keller S, Ridinger J, Rupp AK, Janssen JW
and Altevogt P: Body fluid derived exosomes as a novel template for
clinical diagnostics. J Transl Med. 9:862011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Barok M, Joensuu H and Isola J:
Trastuzumab emtansine: Mechanisms of action and drug resistance.
Breast Cancer Res. 16:2092014. View Article : Google Scholar : PubMed/NCBI
|
